Christopher Clarke
FIA
Principal and Consulting Actuary
London, UK
Christopher Clarke is a principal in Milliman's Property and Casualty Practice in London. He joined the firm in 2010.
Experience
Christopher works with a wide range of clients, including (re)insurers, Lloyd's syndicates, ILS funds, captives, P&I clubs, and other entities. His areas of expertise include:
- Reserving, for a wide range of London Market and commercial lines of business. Christopher has managed projects to provide statements of actuarial opinion for Lloyd's syndicates, as well as insurers in Ireland and Bermuda.
- ILS fund valuation. Christopher leads the quarterly valuation exercise for a leading ILS fund.
- Independent Expert work for insurance business transfers. Christopher is an experienced Independent Expert for Part VII transfers in the UK, and has also worked on Section 13 transfers in Ireland and Insurance Business Transfers in Oklahoma.
- Legacy business. Christopher has particular expertise with regard to legacy business, having undertaken reserve reviews for numerous run-off portfolios, including those with APH liabilities.
- M&A. Christopher has advised both buyers and sellers in insurance-related transactions, in particular those involving legacy liabilities.
- Solvency II. Christopher is experienced in all aspects of the actuarial function role under Solvency II, including calculating technical provisions and solvency capital requirements, as well as all associated reporting.
Professional Designations
- Fellow, Institute and Faculty of Actuaries
Education
- BSc Mathematics
Publications
Read their latest work
Article
CP2/24: Solvent exit planning for insurers
17 July 2024 - by Robert Bugg, Christopher Clarke, Matthew Ford, John Jenkins, Chew Hou Ng
We offer some key takeaways for insurers on the Prudential Regulation Authority’s Consultation Paper 2/24.
Article
Non-Life Part VII Transfers: A Dwindling Trend?
07 December 2023 - by Christopher Clarke
We’re set to see in 2023 the fewest non-life Part VII transfers sanctioned by the UK since the early 2000s. What does the future hold for the strategy?
Article
Reserving Challenges for ILS Funds
01 October 2021 - by Christopher Clarke
We look at some of the major losses that have occurred since 2017 and why they have proved challenging to set reserves for, creating heightened uncertainty in the valuations of ILS funds.
Article
Insurance business transfers of legacy UK employers' liability policies
31 October 2019 - by Christopher Clarke
We examine how UK insurers have sought to dispose of legacy employers’ liability policies in an effort to eliminate problematic long-tail liabilities.
Article
Final Guidance on the FCA’s approach to the review of Part VII insurance business transfers
10 July 2018 - by Christopher Clarke, Emma Hutchinson, Stuart Reynolds
At the end of May, the Financial Conduct Authority published final guidance on its approach to the review of Part VII insurance business transfers.
Article
Part VII transfers and the FCA’s approach to the review
27 December 2017 - by Christopher Clarke, Andrew Gilchrist, Philip Simpson, Lindsay Unwin
What involvement does the Financial Conduct Authority have in Part VII transfers and what are its current expectations?
Article
Milliman Briefing: Insurance business transfers
21 August 2017 - by Robert Bugg, Christopher Clarke, Jennifer Strickland, Jen van der Ree
This paper considers some of the issues associated with insurance business transfers.
Article
Solvency II overview: Where are we now?
10 May 2013 - by Christopher Clarke, Peter Moore, Derek Newton, Vincent Robert, Gary Wells
A roundup of Solvency II compliance requirement and the most recent regulatory guidance.
Article
Issues in brief winter 2012: UK life insurance
04 December 2012 - by Robert Bugg, Christopher Clarke, Neil Dissanayake, Oliver Gillespie, Russell Osman, Philip Simpson
Life insurance trends affecting the UK, Europe, and beyond.
Article
Reserving for APH Liabilities under Solvency II
28 February 2011 - by Christopher Clarke, Derek Newton, Gary Wells
Insurers that handle asbestos, pollution, and health hazard claims will face specific challenges under the new reporting regime.